Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous SPM 927 (lacosamide) as replacement for oral SPM 927 in partial seizures
2004-002322-22Phase 3Completed
- Sponsor
- Schwarz Pharma
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in epilepsy, sponsored by Schwarz Pharma. Started Nov 2004; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2004-002322-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002322-22.